Clinical Trial Update: PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs [Phase 1]

View source ↗

Summary

Phase 1 trial update of PTK787/ZK 222584 in combination with temozolomide and radiation for glioblastoma patients taking enzyme-inducing anti-epileptic drugs; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• PTK787/ZK 222584 (PTK787/ZK 222584)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Glioblastoma | Phase 1 | Status: COMPLETED